Related Experiment Videos
Paraoxonase: another factor in NIDDM cardiovascular disease
1University of Manchester Department of Medicine, UK.
Lancet (London, England)
|September 30, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?
European journal of preventive cardiology·2011
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).
Diabetic medicine : a journal of the British Diabetic Association·2010
Psoriasis.
Lancet (London, England)·2026
A novel gross deletion in the progranulin gene in four subjects with frontotemporal dementia.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
UMOD Genotype and Clinical Outcomes in Heart Failure Patients Treated with Loop Diuretics: A UK Biobank Pharmacogenetic Cohort Study.
Clinical pharmacology and therapeutics·2026
The emerging role of endoscopy in neurogastroenterology.
Current opinion in gastroenterology·2026
Repetitive Transcranial Magnetic Stimulation for Dizziness, Balance, and Postural Stability in Adult Patients With Chronic Peripheral Vestibular Dizziness.
Archives of physical medicine and rehabilitation·2026